Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)

NCT01669811 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1398

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Reflux Esophagitis

Interventions

DRUG: Esomeprazole (D961H) twice daily
DRUG: Esomeprazole (D961H) once daily

Sponsor

AstraZeneca